HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.
2nd Edition of International Heart Congress
June 20-22,2024 | Hybrid Event
Cardiovascular Translational Research
Cardiovascular Translational Research
It is integrated research into the pathogenesis, diagnosis, and treatment of cardiovascular disease. The Strategic Plan’s clinical and translational research goals emphasize the transmission of knowledge between basic and clinical research so that findings in one arena rapidly inform and stimulate research in the cardiovascular field.
Committee Members
Michael E Merhige
State University of NY at Buffalo, United States
Naranjan Dhalla
St. Boniface Hospital Albrechtsen Research Centre, Canada
Timothy F Christian
Albert Einstein College of Medicine, United States Heart Congress 2024 Speakers
Roger H Coletti
Interventional Health, PA, United States
Pedro A Jose
The George Washington University of School of Medicine & Health Sciences, United States
Yong Xiao Wang
Albany Medical Center, United States
Thomas J Webster
Interstellar Therapeutics, United StatesSubmit your abstract Today
Title : Managing total chronic coronary occlusion: Noninvasive External Counterpulsation (ECP) induces collaterogenesis, relieving ischemia, as demonstrated by quantitative PET myocardial perfusion imaging: ECP is a cost-effective alternative to high risk PCI
Michael E Merhige, State University of NY at Buffalo, United States
Title : Effects of impaired microcirculation in the musculoskeletal system
Roger H Coletti, Interventional Health, PA, United States
Title : Cardio nanomedicine: Fighting plaque, opening arteries, and healing hearts
Thomas J Webster, Interstellar Therapeutics, United States
Title : Dopamine D2 receptor and inverse salt sensitivity
Pedro A Jose, The George Washington University of School of Medicine & Health Sciences, United States
Title : Clinical pharmacology of sotagliflozin – Novel quality in treatment of heart failure
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Rationale for the prevention or therapy of sudden cardiac death in heart failure
Naranjan Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada